Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079552625> ?p ?o ?g. }
- W2079552625 endingPage "36" @default.
- W2079552625 startingPage "27" @default.
- W2079552625 abstract "1 RP 62203 (2-[3-(4-(4-fluorophenyl)-piperazinyl)propyl]naphto[1,8-cd]isothiazole-1,1-dioxide) is a novel naphtosultam derivative which shows very high affinity for 5-HT2 receptors in the rat cerebral cortex (Ki = 50.0 pm). 2 RP 62203 is relatively selective for this sub-type of 5-hydroxytryptamine (5-HT) receptor, having lower affinity for the 5-HT1A receptor and very low affinity for the 5-HT3 receptor. RP 62203 displayed low to moderate affinity for α1-adrenoceptors, dopamine D2 receptors and histamine H1 receptors. 3 In vivo binding experiments demonstrated that oral administration of low doses of RP 62203 led to a long-lasting (> 6 h) occupation of cortical 5-HT2 receptors (ID50 = 0.39 mg kg−1). 4 In cortical slices from the neonatal rat, RP 62203 potently inhibited inositol phosphate formation evoked by 5-HT, with an IC50 of 7.76 nm. 5 The activity of neurones in the raphé and their responses to microiontophoretically applied 5-HT were studied with extracellular recording electrodes in the anaesthetized rat. RP 62203 potently and dose-dependently blocked excitations evoked by 5-HT when administered at doses of 0.5–4.0 mg kg−1, i.p. In contrast, neither 5-HT-evoked depressions nor glutamate-evoked excitations of raphé neuronal firing were blocked by RP 62203 at doses as high as 8.0 mg kg−1 i.p. 6 Head twitches induced by 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) could be abolished by low doses of RP 62203 in mice (ED50 = 0.44 mg kg−1, p.o.) and in rats (ED50 = 1.54 p.o.). Similar results were obtained with mescaline and 5-hydroxytryptophan (5-HTP). 7 The potency of RP 62203 was compared with that of three other 5-HT2 receptor antagonists, ritanserin, ICI 169,369 and ICI 170,809. In all models, RP 62203 showed similar activity to ritanserin, whilst either ICI 169,369 or ICI 170,809 was several fold less active. 8 It is concluded that RP 62203 is a potent and selective antagonist at 5-HT2 receptors in the rodent central nervous system." @default.
- W2079552625 created "2016-06-24" @default.
- W2079552625 creator A5006743494 @default.
- W2079552625 creator A5016013370 @default.
- W2079552625 creator A5016110181 @default.
- W2079552625 creator A5023428701 @default.
- W2079552625 creator A5028581903 @default.
- W2079552625 creator A5067208014 @default.
- W2079552625 creator A5069308670 @default.
- W2079552625 creator A5076595169 @default.
- W2079552625 creator A5076615876 @default.
- W2079552625 creator A5080758555 @default.
- W2079552625 creator A5085517573 @default.
- W2079552625 date "1992-01-01" @default.
- W2079552625 modified "2023-10-18" @default.
- W2079552625 title "Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist" @default.
- W2079552625 cites W159198934 @default.
- W2079552625 cites W1809659791 @default.
- W2079552625 cites W1889236699 @default.
- W2079552625 cites W1929026110 @default.
- W2079552625 cites W1969078149 @default.
- W2079552625 cites W1971303925 @default.
- W2079552625 cites W1972947861 @default.
- W2079552625 cites W1974195654 @default.
- W2079552625 cites W1975514155 @default.
- W2079552625 cites W1978320799 @default.
- W2079552625 cites W1979067089 @default.
- W2079552625 cites W1981264895 @default.
- W2079552625 cites W1984692581 @default.
- W2079552625 cites W1986031230 @default.
- W2079552625 cites W1988705766 @default.
- W2079552625 cites W1995743650 @default.
- W2079552625 cites W1996997570 @default.
- W2079552625 cites W1997636185 @default.
- W2079552625 cites W2001391508 @default.
- W2079552625 cites W2003686526 @default.
- W2079552625 cites W2005395166 @default.
- W2079552625 cites W2005808435 @default.
- W2079552625 cites W2009164474 @default.
- W2079552625 cites W2009821818 @default.
- W2079552625 cites W2012698769 @default.
- W2079552625 cites W2022199444 @default.
- W2079552625 cites W2026136209 @default.
- W2079552625 cites W2028046140 @default.
- W2079552625 cites W2028569155 @default.
- W2079552625 cites W2029288211 @default.
- W2079552625 cites W2032560869 @default.
- W2079552625 cites W2034961437 @default.
- W2079552625 cites W2038667105 @default.
- W2079552625 cites W2039784556 @default.
- W2079552625 cites W2045877095 @default.
- W2079552625 cites W2046229452 @default.
- W2079552625 cites W2051921786 @default.
- W2079552625 cites W2054676102 @default.
- W2079552625 cites W2055213777 @default.
- W2079552625 cites W2059250402 @default.
- W2079552625 cites W2060172635 @default.
- W2079552625 cites W2066462196 @default.
- W2079552625 cites W2066663898 @default.
- W2079552625 cites W2068196787 @default.
- W2079552625 cites W2069027411 @default.
- W2079552625 cites W2082349694 @default.
- W2079552625 cites W2087221796 @default.
- W2079552625 cites W2087396777 @default.
- W2079552625 cites W2090012260 @default.
- W2079552625 cites W2091269938 @default.
- W2079552625 cites W2092481738 @default.
- W2079552625 cites W2092948253 @default.
- W2079552625 cites W2096887339 @default.
- W2079552625 cites W2115250531 @default.
- W2079552625 cites W2144357283 @default.
- W2079552625 cites W2149791248 @default.
- W2079552625 cites W2154588586 @default.
- W2079552625 cites W2158907779 @default.
- W2079552625 cites W2307484198 @default.
- W2079552625 cites W2322365578 @default.
- W2079552625 cites W2400755806 @default.
- W2079552625 cites W2413888254 @default.
- W2079552625 cites W2416473705 @default.
- W2079552625 cites W2478534625 @default.
- W2079552625 cites W4232534952 @default.
- W2079552625 doi "https://doi.org/10.1111/j.1476-5381.1992.tb14206.x" @default.
- W2079552625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1908636" @default.
- W2079552625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1596688" @default.
- W2079552625 hasPublicationYear "1992" @default.
- W2079552625 type Work @default.
- W2079552625 sameAs 2079552625 @default.
- W2079552625 citedByCount "47" @default.
- W2079552625 countsByYear W20795526252015 @default.
- W2079552625 countsByYear W20795526252016 @default.
- W2079552625 countsByYear W20795526252018 @default.
- W2079552625 countsByYear W20795526252019 @default.
- W2079552625 countsByYear W20795526252022 @default.
- W2079552625 crossrefType "journal-article" @default.
- W2079552625 hasAuthorship W2079552625A5006743494 @default.
- W2079552625 hasAuthorship W2079552625A5016013370 @default.
- W2079552625 hasAuthorship W2079552625A5016110181 @default.
- W2079552625 hasAuthorship W2079552625A5023428701 @default.